85 related articles for article (PubMed ID: 15094600)
1. [An aggressive subtype of breast carcinoma].
Dauplat MM; Mishellany F; Delatour M; Penault-Llorca F
Ann Pathol; 2003 Dec; 23(6):611-2. PubMed ID: 15094600
[No Abstract] [Full Text] [Related]
2. [Clinical-biological meaning of progesterone receptor status in 118 estrogen receptor positive infiltrating ductal carcinomas of the breast in post-menopausal women].
Ruibal A; Schneider J; Arias J; del Río MC; Núnez MJ; Tejerina A
Rev Esp Med Nucl; 2000 Jun; 19(3):244-6. PubMed ID: 11062090
[No Abstract] [Full Text] [Related]
3. [Metaplastic carcinomas of the breast: a morphological and immunohistochemical study].
Gauchotte G; Gauchotte E; Bressenot A; Verhaeghe JL; Guillemin F; Leroux A; Genin P
Ann Pathol; 2011 Feb; 31(1):18-27. PubMed ID: 21349384
[TBL] [Abstract][Full Text] [Related]
4. Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
Charafe-Jauffret E; Tarpin C; Bardou VJ; Bertucci F; Ginestier C; Braud AC; Puig B; Geneix J; Hassoun J; Birnbaum D; Jacquemier J; Viens P
J Pathol; 2004 Mar; 202(3):265-73. PubMed ID: 14991891
[TBL] [Abstract][Full Text] [Related]
5. Metaplastic carcinoma of the breast: analysis of eight Asian patients with special emphasis on two unusual cases presenting with inflammatory-type breast cancer.
Kuo SH; Chen CL; Huang CS; Cheng AL
Anticancer Res; 2000; 20(3B):2219-22. PubMed ID: 10928181
[TBL] [Abstract][Full Text] [Related]
6. Relationships between epidermal growth factor receptor (EGF-R) and other predictors of prognosis in breast carcinomas. An immunohistochemical study.
Martinazzi M; Crivelli F; Zampatti C; Martinazzi S
Pathologica; 1993; 85(1100):637-44. PubMed ID: 8170712
[TBL] [Abstract][Full Text] [Related]
7. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
[TBL] [Abstract][Full Text] [Related]
8. [Occult multicentric breast cancer].
Vtorushin SV; Zab'ialova MV; Glushchenko SA; Perel'muter VM; Slonimskaia EM
Vopr Onkol; 2009; 55(1):38-41. PubMed ID: 19435197
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical investigation of estrogen and progesterone receptors in breast tumors].
Ellinidi VN; Anikseeva NV; Goncharova OA; Krasnozhon DA; Fedorov KA
Vopr Onkol; 2004; 50(2):234-6. PubMed ID: 15176229
[TBL] [Abstract][Full Text] [Related]
10. [Breast carcinoma metastatic to meningioma: review of the literature and description of 2 new cases].
Fornelli A; Bacci A; Collina G; Eusebi V
Pathologica; 1995 Oct; 87(5):506-12. PubMed ID: 8868176
[TBL] [Abstract][Full Text] [Related]
11. [Epidermal growth factor receptor as a prognostic factor of breast cancers].
Tsutsui S
Nihon Rinsho; 2000 Apr; 58 Suppl():442-7. PubMed ID: 11026031
[No Abstract] [Full Text] [Related]
12. [Loss of hormonal receptors expression from primary breast carcinoma to axillary lymph node metastases].
Cianga C; Cianga P; Cozma L; Diaconu C; Carasevici E
Rev Med Chir Soc Med Nat Iasi; 2003; 107(3):540-4. PubMed ID: 14756058
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
Temmim L; Baker H; Sinowatz F
Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer: pathological and immunohistochemical features.
Willsher PC; Leach IH; Ellis IO; Bell JA; Elston CW; Bourke JB; Blamey RW; Robertson JF
Anticancer Res; 1997; 17(3C):2335-8. PubMed ID: 9245247
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of epidermal growth factor receptor lacks prognostic significance for breast carcinoma.
Göhring UJ; Ahr A; Scharl A; Weisner V; Neuhaus W; Crombach G; Holt JA
J Soc Gynecol Investig; 1995; 2(4):653-9. PubMed ID: 9420872
[TBL] [Abstract][Full Text] [Related]
17. Correlation of steroid receptors with histopathologic characteristics in breast carcinoma.
Bhatavdekar JM; Trivedi SN; Shah NG; Karelia NH; Patel DD; Giri DD; Patel TB
Neoplasma; 1988; 35(4):413-23. PubMed ID: 3185838
[TBL] [Abstract][Full Text] [Related]
18. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology.
Lim S; Janzer A; Becker A; Zimmer A; Schüle R; Buettner R; Kirfel J
Carcinogenesis; 2010 Mar; 31(3):512-20. PubMed ID: 20042638
[TBL] [Abstract][Full Text] [Related]
19. [Current aspects in histopathological assessment of breast cancer].
Sastre X
Bull Cancer; 1997 Jan; 84(1):65-8. PubMed ID: 9180862
[TBL] [Abstract][Full Text] [Related]
20. Differentiation pathways in primary invasive breast carcinoma as suggested by intermediate filament and biopathological marker expression.
Santini D; Ceccarelli C; Taffurelli M; Pileri S; Marrano D
J Pathol; 1996 Aug; 179(4):386-91. PubMed ID: 8869285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]